- Home
- BMRN vs ALB Comparison
BMRN vs ALB Comparison
Compare BMRN & ALB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- ALB
- Stock Information
- Founded
- BMRN 1996
- ALB 1994
- Country
- BMRN United States
- ALB United States
- Employees
- BMRN N/A
- ALB N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- ALB Major Chemicals
- Sector
- BMRN Health Care
- ALB Industrials
- Exchange
- BMRN Nasdaq
- ALB Nasdaq
- Market Cap
- BMRN 13.7B
- ALB 11.7B
- IPO Year
- BMRN 1999
- ALB 1994
- Fundamental
- Price
- BMRN $59.17
- ALB $52.91
- Analyst Decision
- BMRN Buy
- ALB Hold
- Analyst Count
- BMRN 22
- ALB 19
- Target Price
- BMRN $94.00
- ALB $93.95
- AVG Volume (30 Days)
- BMRN 2.0M
- ALB 3.8M
- Earning Date
- BMRN 05-01-2025
- ALB 04-30-2025
- Dividend Yield
- BMRN N/A
- ALB 3.06%
- EPS Growth
- BMRN 153.71
- ALB N/A
- EPS
- BMRN 2.21
- ALB N/A
- Revenue
- BMRN $2,853,915,000.00
- ALB $5,377,526,000.00
- Revenue This Year
- BMRN $12.23
- ALB N/A
- Revenue Next Year
- BMRN $9.93
- ALB $13.32
- P/E Ratio
- BMRN $26.81
- ALB N/A
- Revenue Growth
- BMRN 17.97
- ALB N/A
- 52 Week Low
- BMRN $52.93
- ALB $49.43
- 52 Week High
- BMRN $94.85
- ALB $137.50
- Technical
- Relative Strength Index (RSI)
- BMRN 37.64
- ALB 32.35
- Support Level
- BMRN $52.93
- ALB $51.46
- Resistance Level
- BMRN $60.93
- ALB $59.24
- Average True Range (ATR)
- BMRN 3.18
- ALB 5.14
- MACD
- BMRN -0.53
- ALB -0.92
- Stochastic Oscillator
- BMRN 34.01
- ALB 14.37
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About ALB Albemarle Corporation
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.